ID: ALA3922463

Max Phase: Preclinical

Molecular Formula: C16H10Br2N2O3

Molecular Weight: 438.07

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c2n(C)ccc3c-2n(c(=O)c1=O)c1c(Br)cc(Br)cc31

Standard InChI:  InChI=1S/C16H10Br2N2O3/c1-19-4-3-8-9-5-7(17)6-10(18)11(9)20-12(8)13(19)15(23-2)14(21)16(20)22/h3-6H,1-2H3

Standard InChI Key:  JIIOXXNPXZNGJJ-UHFFFAOYSA-N

Associated Targets(non-human)

Meriones unguiculatus 417 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 438.07Molecular Weight (Monoisotopic): 435.9058AlogP: 3.23#Rotatable Bonds: 1
Polar Surface Area: 52.71Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.86CX LogD: 2.86
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.43Np Likeness Score: 0.01

References

1. Sasaki T, Li W, Ohmoto T, Koike K..  (2016)  Evaluation of canthinone alkaloids as cerebral protective agents.,  26  (20): [PMID:27623547] [10.1016/j.bmcl.2016.09.006]

Source